Clinical and pharmacoeconomic profile of lanthanum carbonate treatment of hyperphosphataemia in chronic renal dialysis patients

by Mario Eandi
Published 2010-03-01

Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials

by Fang Wang, Xiangxue  Lu, Jingli Zhang, Ruifang Xiong, Han Li, Shixiang Wang
Published 2018-03-01

Gastropathy associated with lanthanum phosphate deposition that was endoscopically tracked for 3 years. A case report

by Akiko Ohno, Jun Miyoshi, Hidesato Tanabe, Mitsunori Kusuhara, Masao Toki, Tomohiro Chiba, Hiroaki Shimoyamada, Junji Shibahara, Tadakazu Hisamatsu
Published 2020-08-01

Relationship between Gut Microbiota and Phosphorus Metabolism in Hemodialysis Patients: A Preliminary Exploration

by Yuan-Yi Miao, Cong-Min Xu, Min Xia, Huai-Qiu Zhu, Yu-Qing Chen
Published 2018-01-01

Lanthanum carbonate for dialysis patients with hyperphosphataemia resistant to sevelamer: A retrospective cohort study

by Asrar Khan, Titi Chen, Anis Khan, Elaine Chan, Karen Byth, Jackson Tan, David Harris
Published 2016-12-01

Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?

by Agnieszka Pozdzik, Cristina David, Jelle Vekeman, Frederik Tielens, Michel Daudon
Published 2021-07-01

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of d...

by Hutchison Alastair J, Gill Maggie, Copley J Brian, Poole Lynne, Wilson Rosamund J
Published 2013-02-01

Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis

by Kentaro Watanabe, Hideki Fujii, Keiji Kono, Shunsuke Goto, Shinichi Nishi
Published 2020-01-01

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale

by Luca Di Lullo, Rodolfo Rivera, Antonio De Pascalis, Fulvio Floccari, Vincenzo Barbera, Claudio Ronco, Alberto Santoboni1
Published 2015-03-01

Assessment of the application for renewal of authorisation of Lantharenol® (lanthanum carbonate octahydrate) for cats

by EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Christensen, Birgit Dusemund, Maryline Kouba, Mojca Kos Durjava, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Yolanda Sanz, Roberto Edoardo Villa, Ruud Woutersen, Andrew Chesson, Jürgen Gropp, Giovanna Martelli, Derek Renshaw, Gloria López‐Gálvez, Alberto Mantovani
Published 2019-01-01

Comparative analysis of the phosphate-binding effects of sucroferric oxyhydroxide, ferric citrate, and lanthanum carbonate

by Takeo Ishii, Yukiko Nakajima, Kunio Oyama
Published 2017-09-01

Lanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China

by Xu Jing, Zhang Yi-Xiang, Yu Xue-Qing, Liu Zhi-Hong, Wang Li-Ning, Chen Jiang-Hua, Fan Ya-Ping, Ni Zhao-Hui, Wang Mei, Yuan Fa-Huan, Ding Guo-Hua, Chen Xiang-Mei, Zhang Ai-Ping, Mei Chang-Lin
Published 2013-02-01

Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease

by Cernaro V, Calimeri S, Laudani A, Santoro D
Published 2020-09-01

Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia

by Rosamund J Wilson, J Brian Copley
Published 2017-01-01

Lanthanum carbonate oral powder: satisfaction, preference and adherence in French and Spanish patients with end-stage renal disease

by Michael Keith, Patricia de Sequera, Francois Clair, Riccardo Pedersini
Published 2016-10-01